India, Feb. 27 -- Eleven CRDMOs collaborate to form IPSO with the aim to elevate India's position in the global pharmaceutical value-chain Report states that India's CRDMO sector is poised for rapid growth with strong fundamentals and global realignments, focusing on leading-edge science and technology Hyderabad - The Indian Contract Research, Development, and Manufacturing Organization (CRDMO) sector is at an inflection point, with the potential to grow to $22 - $25 billion by 2035, as revealed in a new report, Unleashing the Tiger: Indian CRDMO Sector 2025, published by Boston Consulting Group (BCG) and Innovative Pharmaceutical Services Organization (IPSO). The report highlights India's strong foundation in small molecule capabilities, s...